Future clinical pharmacy practitioners should be board-certified specialists.
نویسندگان
چکیده
The vision of the American College of Clinical Pharmacy (ACCP) is that, in 20–30 years, most clinical pharmacy practitioners will be boardcertified specialists. 2 This White Paper develops a rationale for this position, describes specialty board certification in pharmacy, and articulates recommendations for attaining the vision. The justification of the need for board certification as a part of future quality assurance and professional privileging processes, the rationale for the argument that most future clinical faculty and residency preceptors should be board certified, and the identification of obstacles that hinder achieving this vision are also discussed.
منابع مشابه
Board of Regents commentary. Qualifications of pharmacists who provide direct patient care: perspectives on the need for residency training and board certification.
In 2006, the American College of Clinical Pharmacy (ACCP) released a position statement and a white paper to provide the College's viewpoints on the importance of postgraduate pharmacy residency training as a prerequisite for direct patient care practice and the vision that future clinical pharmacists engaged in direct patient care would be certified by the Board of Pharmacy Specialties (BPS). ...
متن کاملRecommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapy.
Recently created guidelines for the development of institutional antimicrobial stewardship programs recommend that a pharmacist with infectious diseases training be included as a core member of the antimicrobial stewardship team. However, training and certification requirements for infectious diseases-trained clinical pharmacists have not been established. Although pharmacists have nurtured the...
متن کاملImpact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice.
This paper describes the goals of the American Society of Health-System Pharmacists' Pharmacy Practice Model Initiative (PPMI) and its recommendations for health-system pharmacy practice transformation to meet future patient care needs and elevate the role of pharmacists as patient care providers. PPMI envisions a future in which pharmacists have greater responsibility for medication-related ou...
متن کاملSunitinib Induced Immune Thrombocytopenia
Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...
متن کاملSunitinib Induced Immune Thrombocytopenia
Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Pharmacotherapy
دوره 26 12 شماره
صفحات -
تاریخ انتشار 2006